Commentary: Aspirin and cancer prevention
Author:
Open Access
- 1 October 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 36 (5) , 957-959
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2007
- Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States)Cancer Causes & Control, 2006
- Aspirin and cancer risk: an updated quantitative review to 2005Cancer Causes & Control, 2006
- Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressProceedings of the National Academy of Sciences, 2005
- Genetic Variants in the UGT1A6 Enzyme, Aspirin Use, and the Risk of Colorectal AdenomaJNCI: Journal of the National Cancer Institute, 2005
- A Prospective Study of Aspirin Use and the Risk for Colorectal AdenomaAnnals of Internal Medicine, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- Colorectal Cancer Chemoprevention with AspirinGastrointestinal Oncology, 2002
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991